A comparison of once and twice daily atenolol in hypertension
Open Access
- 1 November 1977
- journal article
- clinical trial
- Published by Oxford University Press (OUP)
- Vol. 53 (625), 679-682
- https://doi.org/10.1136/pgmj.53.625.679
Abstract
Summary: The hypertensive action of atenolol has been studied in a randomized double-blind crossover comparison. Twelve patients showed a highly significant reduction in average supine systolic and diastolic blood pressures from pre-treatment values of 196.3/115.9 to 159.1/89.2 mmHg (26.1/15.4 kPa to 22.2/11.9 kPa) after 2 weeks on once daily atenolol. No dose-related reduction in blood pressure was seen and the single 100 mg daily dose was as effective as 100 mg twice daily or 50 mg twice daily. Blood pressures recorded after 2 weeks' atenolol were lower than those obtained at 7 days irrespective of dose.Keywords
This publication has 5 references indexed in Scilit:
- Raynaud's phenomenon as side effect of beta-blockers in hypertension.BMJ, 1976
- Atenolol in essential hypertensionClinical Pharmacology & Therapeutics, 1976
- Once-daily dosing with Atenolol in patients with mild or moderate hypertension.BMJ, 1976
- Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta‐adrenoceptor blocking drug.British Journal of Clinical Pharmacology, 1976
- The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.1976